Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Your blood pressure pill might be doing more than you think. Researchers at Rockefeller University found that losartan, a widely used ARB medication, can activate brown fat — the body's calorie-burning tissue — through a mechanism entirely separate from its blood pressure effects. A massive analysis of 100,000+ patients also revealed that people with detectable brown fat had lower rates of heart disease, diabetes, anxiety, and depression.
Your blood pressure pill might be pulling double duty. Scientists at Rockefeller University discovered that losartan — a commonly prescribed angiotensin receptor blocker (ARB) — can activate brown fat, the specialized tissue that burns energy rather than storing it. Crucially, this effect operates through molecular pathways separate from its blood pressure-lowering mechanism, meaning future therapies could potentially stimulate brown fat in people with normal blood pressure.
The team also uncovered a surprising mental health angle: people with detectable brown fat had lower rates of anxiety and depression. Interestingly, SSRIs — common antidepressants — appeared to suppress brown fat activity, hinting at a complex interplay between psychiatric treatments and metabolic health.
By the Numbers:
Why it matters: This research opens the door to repurposing an already-safe, widely available drug to treat metabolic conditions — and potentially psychiatric ones too. It also raises new questions about how brown fat location, not just presence, shapes health outcomes.